David Hoon, MSc, Ph.D.

John Wayne Cancer Institute
email: hoonD@jwci.org

Grants

Multimarker miR Blood Assay for Breast Cancer Detection 2010 (Cycle 16)
IDEA (Innovative, Developmental, and Exploratory Awards) 16IB-0076 $265,415
ID4: a Prognostic Factor of Breast Cancer Metastasis 2005 (Cycle 11)
IDEA (Innovative, Developmental, and Exploratory Awards) 11IB-0166 $283,200
Translational Proteomics of Normal to Benign Breast Disease 2003 (Cycle IX)
TRC (Translational Research Collaboration) Pilot Awards 9DB-0098 $188,044
Clinical Utility of Breast Cancer DNA Markers in Serum 2001 (Cycle VII)
STEP Award 7WB-0021 $470,520
Clinical Utility of Breast Cancer DNA Markers in Plasma 1999 (Cycle V)
IDEAS II 5JB-0045 $372,242


Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.
  Periodical: Clinical Chemistry
  Author(s): Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DS
  Yr: 2011 Vol: 57 Nbr: 1 Pgs: 84-91
  Associated Grant: Multimarker miR Blood Assay for Breast Cancer Detection
 
Identification of tumor-specific genetic alterations in the bone marrow of early stage breast cancer patients.
  Periodical: Proceedings of the American Association for Cancer Research
  Author(s): Taback B, Giuliano A, Hansen N, Singer R, Hoon D
  Yr: 2003 Vol: 44 Nbr: Pgs: 563
  Associated Grant: Clinical Utility of Breast Cancer DNA Markers in Serum
 
Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients
  Periodical: Cancer Research
  Author(s): Taback B, Giuliano AE, Hansen NM, Singer FR, Shu S, Hoon DS
  Yr: 2003 Vol: 63 Nbr: 8 Pgs: 1884-7
  Associated Grant: Clinical Utility of Breast Cancer DNA Markers in Serum
 
Microsatellite alterations detected in the serum of early stage breast cancer patients.
  Periodical: Annals of the New York Academy of Sciences
  Author(s): Taback B, Giuliano AT, Hansen NM, Hoon DSB.
  Yr: 2001 Vol: 945 Nbr: Pgs: 22-30
  Associated Grant: Clinical Utility of Breast Cancer DNA Markers in Plasma
 
Microsatellite alterations detected in the serum of early stage breast cancer patients
  Periodical: Annals of the New York Academy of Sciences
  Author(s): Taback B, Giuliano AE, Hansen NM, Hoon DSB
  Yr: 2001 Vol: 945 Nbr: Pgs: 22-30
  Associated Grant: Clinical Utility of Breast Cancer DNA Markers in Serum